The Pathologic Significance of the Immunoglobulins Expressed by Chronic Lymphocytic Leukemia B-cells in the Development of Autoimmune Hemolytic Anemia

References

• Rosenthal M. C., Pisciotla A. V., Komninos Z. D., Goldenberg H., Dameshek W. The autoimmune hemolytic anemia of malignant lymphocytic disease. Blood 1955; 10: 197–203
   PubMed Web of Science ®Google Scholar
• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: New insights into biology and therapy. Ann. Int. Med. 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J.-L., the French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• Hamblin T. J., Oscier D. J., Young B. J. Autoimmunity in chronic lymphocytic leukemia. J. Clin. Pathol. 1986; 39: 713–716
   PubMed Web of Science ®Google Scholar
• De Rossi G., Granati L., Girelli G., Gandolfo G., Arista M. C., Martelli M., Conti L., Marini R., La Tagliata R., Leone R., Mandelli F. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia. Nouv. Rev. Fr. Hemalol 1988; 30: 403–406
   PubMedGoogle Scholar
• Kipps T. J. Chronic lymphocytic leukemia and related diseases. Williams Hematology, E. Beutler, M. A. Lichtman, B. S. Coller, T. J. Kipps. McGraw-Hill, New York 1995; 1017–1039
   Google Scholar
• Majumdar G., Brown S., Slater N. G., Singh A. K. Clinical spectrum of autoimmune haemolytic anemia in patients with chronic lymphocytic leukemia. Leak. Lymphoma 1993; 9: 149–151
   PubMed Web of Science ®Google Scholar
• Siegel D. L., Silberstein L. E. Red blood cell autoantibodies. Scientific basis of transfusion medicine: Implications for clinical practice, K. C. Anderson, P. M. Ness. W.B. Saunders, Philadelphia 1994; 517–526
   Google Scholar
• Feizi T., Wernet P., Kunkel H. G., Douglas S. D. Lymphocytes forming red cell rosettes in the cold in patients with chronic cold agglutinin disease. Blood 1973; 42: 753–762
   PubMed Web of Science ®Google Scholar
• Engelfriet C. P., Overbeeke M. A. M., von dem Borne A. E. G. K. Autoimmune hemolytic anemia. Sem. Hematol. 1992; 29: 3–12
   PubMed Web of Science ®Google Scholar
• Kobayashi R., Picchio G., Kirven M., Meisenholder G., Baird S., Carson D. A., Mosier D. E., Kipps T. J. Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leuk. Res. 1992; 16: 1013–1023
   PubMed Web of Science ®Google Scholar
• Andrzejewski C., Jr., Young P. J., Cines D. B., Silberstein L. E. Heterogeneity of human red cell autoantibodies assessed by isoelectric focusing. Transfusion 1991; 31: 236–244
   PubMed Web of Science ®Google Scholar
• Sthoeger Z. M., Sthoeger D., Shtalrid M., Sigler E., Geltner D., Berrebi A. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am. J. Hematol 1993; 43: 259–264
   PubMed Web of Science ®Google Scholar
• Efremov D. G., Ivanovski M., Batista F. D., Pozzato G., Burrone O. R. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J. Clin. Invest. 1996; 98: 290–298
   PubMed Web of Science ®Google Scholar
• Fais F., Sellars B., Ghiotto F., Yan X.-J., Dono M., Allen S. L., Budman D., Dittmar K., Kolitz J., Lichtman S. M., Schulman P., Schuster M., Vinciguerra V. P., Rai K., Stevenson F. K., Gregersen P. K., Ferrarini M., Chiorazzi N. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B-cells. J. Clin. Invest. 1996; 98: 1659–1666
   PubMed Web of Science ®Google Scholar
• Phillips J., Mehta K., Fernandez C., Raveche E. The NZB mouse as a model for CLL. Cancer Res. 1992; 52: 437–443
   PubMed Web of Science ®Google Scholar
• Hardy R. R., Hayakawa K. CD5 B-cells, a fetal B-cell lineage. Adv. Immunol. 1994; 55: 297–339
   PubMed Web of Science ®Google Scholar
• Izui S. Autoimmune hemolytic anemia. Curr. Opin. Immunol. 1994; 6: 926–930
   PubMed Web of Science ®Google Scholar
• Reininger L., Ollier P., Poncet P., Kaushik A., Jaton J.-C. Novel V genes encode virtually identical variable regions of six murine monoclonal anti-bromelain-treated red blood cell autoantibodies. J. Immunol. 1987; 138: 316–323
   PubMed Web of Science ®Google Scholar
• Hardy R. R., Carmack C. E., Shinton S. A., Riblet R. J., Hayakawa K. A single VH gene is utilized predominantly in anti-BrMrbc hybridomas derived from purified Ly-1 B cells: Definition of the VH11 family. J. Immunol. 1989; 142: 3643–3651
   PubMed Web of Science ®Google Scholar
• Kaushik A., Matthes T., Dighiero G. Do natural autoantibodies play an important role in the elimination of senescent or damaged red blood cells?. Blood Cells 1988; 14: 161–174
   PubMedGoogle Scholar
• Murakami M., Yoshioka H., Shirai T., Tsubata T., Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 1994; 7: 877–882
   Web of Science ®Google Scholar
• Kipps T. J., Carson D. A. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 1993; 81: 2475–2487
   PubMed Web of Science ®Google Scholar
• Preud'homme J. L., Seligmann M. Anti-human immunoglobulin G activity of membrane-bound immunoglobulin M in lymphoproliferative disorders. Proc. Natl. Acad. Sci. USA 1972; 69: 2132–2135
   PubMed Web of Science ®Google Scholar
• Broker B. M., Klajman A., Youinou P., Jouquan J., Worman C. P., Murphy J., Mackenzie L., Quartey-Papafio R., Blaschek M., Collins P., Lai S., Lydyard P. M. Chronic lymphocytic leukemia (CLL) cells secrete multispecific autoantibodies. J. Autoimmun. 1988; 1: 469–481
   PubMed Web of Science ®Google Scholar
• Sthoeger Z. M., Wakai M., Tse D. B., Vinciguerra V. P., Allen S. L., Budman D. R., Lichtman S. M., Schulman P., Weiselberg L. R., Chiorazzi N. Production of autoantibodies by CD5-expressing B-lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 1989; 169: 255–268
   PubMed Web of Science ®Google Scholar
• Borche L., Lim A., Binet J. L., Dighiero G. Evidence that chronic lymphocytic leukemia B-lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990; 76: 562–569
   PubMed Web of Science ®Google Scholar
• Martin T., Duffy S. R., Carson D. A., Kipps T. J. Evidence for somatic selection of natural autoantibodies. J. Exp. Med. 1992; 175: 983–991
   PubMed Web of Science ®Google Scholar
• Kipps T. J. Immunoglobulin genes in chronic lymphocytic leukemia. Blood Cells 1993; 19: 615–625
   PubMedGoogle Scholar
• Schroeder H. W., Jr., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol. Today 1994; 15: 288–294
   PubMedGoogle Scholar
• Pascual V., Capra J. D. VH4–21, a human VH gene segment overrepresented in the autoimmune repertoire. Arthritis. Rheum. 1992; 35: 11–18
   PubMed Web of Science ®Google Scholar
• Schutte M. E. M., van Es J. H., Silberstein L. E., Logtenberg T. VH4.21-encoded natural autoantibodies with anti-i specificity mirror those associated with cold hemagglutinin disease. J. Immunol. 1993; 151: 6569–6576
   PubMed Web of Science ®Google Scholar
• Casali P., Schettino E. W. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. 1996; 210: 167–179
   PubMed Web of Science ®Google Scholar
• Okamoto M., Murakami M., Shimuzu A., Ozaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 1992; 175: 71–79
   PubMed Web of Science ®Google Scholar
• Murakami M., Tsubata T., Okamoto M., Shimuzu A., Kumagai S., Imura H., Honjo T. Antigen-induced apoptotic death of Ly-1 B-cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357: 77–80
   PubMed Web of Science ®Google Scholar
• Murakami M., Tsubata T., Shinkura R., Nisitani S., Okamoto M., Yoshioka H., Usui T., Miyawaki S., Honjo T. Oral administration of lipopolysacharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med 1994; 10: 111–122
   Web of Science ®Google Scholar
• Efremov D. G., Ivanovski M., Siljanovski N., Pozzato G., Cevreska L., Fais F., Chiorazzi N., Batista F. D., Burrone O. R. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 1996; 87: 3869–3876
   PubMed Web of Science ®Google Scholar
• Sikora K., Krikorian J., Levy R. Monoclonal immunoglobulin rescue from a patient with chronic lymphocytic leukemia and autoimmune hemolytic anemia. Blood 1979; 54: 513–518
   PubMed Web of Science ®Google Scholar
• Dighiero G. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL. Nouv. Rev. Fr. Hematol 1988; 30: 283–288
   PubMedGoogle Scholar
• Caligaris-Cappio F. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 1996; 87: 2615–2620
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Activated T-cells induce expression of B7/BB1 on normal or leukemic B-cells through a CD40-dependent signal. J. Exp. Med. 1993; 177: 925–935
   PubMed Web of Science ®Google Scholar
• Dazzi F., D'Andrea E., Biasi G., De Silvestro G., Gaidano G., Schena M., Tison T., Vianello F., Girolami A., Caligaris-Cappio F. Failure of B-cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin. Immunol. Immunopathol 1995; 75: 26–31
   PubMedGoogle Scholar
• Kay M. M. B. Mechanism of removal of senescent cells by human macrophages in situ. Proc. Natl. Acad. Sci. USA 1975; 72: 3521–3525
   PubMed Web of Science ®Google Scholar
• Alderman E. M., Fudenburg H. H., Lovins R. E. Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifu-gation. Blood 1980; 55: 817–822
   PubMed Web of Science ®Google Scholar
• Kay M. M. B. Localization of senescent cell antigen on band 3. Proc. Natl. Acad. Sci. USA 1984; 81: 5753–5757
   PubMed Web of Science ®Google Scholar
• Garratty G. The significance of IgG on the red cell surface. Transf. Med. Rev. 1987; 1: 47–57
   PubMedGoogle Scholar
• Roosnek E., Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B-cells. J. Exp. Med. 1991; 173: 487–489
   PubMed Web of Science ®Google Scholar
• Tighe H., Chen P. P., Tucker R., Kipps T. J., Roudier J., Jirik F. R., Carson D. A. Function of B-cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J. Exp. Med. 1993; 177: 109–118
   PubMed Web of Science ®Google Scholar
• Barker R. N., Elson C. J. Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T-cells in vitro. Eur. J. Immunol. 1994; 24: 1578–1582
   PubMed Web of Science ®Google Scholar
• Perry F. E., Barker R. N., Mazza G., Day M. J., Wells A. D., Shen C.-R., Schofield A. E., Elson C. J. Autoreactive T-cell specificity in autoimmune hemolytic anemia of the NZB mouse. Eur. J. Immunol 1996; 26: 136–141
   PubMed Web of Science ®Google Scholar
• Crowley J. J., Goldfien R. D., Schrohenloher R. E., Spiegelberg H. L., Silverman G. J., Mageed R. A., Jefferis R., Koopman W. J., Carson D. A., Fong S. Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J. Immunol. 1988; 140: 3411–3418
   PubMed Web of Science ®Google Scholar
• Borretzen M., Randen I., Natvig J. B., Thompson K. M. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J. Immunol 1995; 155: 3630–3637
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Duffy S. F. Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoanti-body-associated cross-reactive idiotypes. J. Clin. Invest. 1991; 87: 2087–2096
   PubMed Web of Science ®Google Scholar
• Carson D. A., Chen P. P., Kipps T. J. New roles for rheumatoid factor. J. Clin. Invest. 1991; 87: 379–383
   PubMed Web of Science ®Google Scholar
• Sasso E. H., Johnson T., Kipps T. J. Expression of the immunoglobulin VH gene 51 pi is proportional to its germline gene copy number. J. Clin. Invest. 1996; 97: 2074–2080
   PubMed Web of Science ®Google Scholar
• Pritsch O., Magnac C., Dumas G., Egile C., Dighiero G. V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 1993; 82: 3103–3112
   PubMed Web of Science ®Google Scholar
• Martin T., Crozier R., Weber J.-C., Kipps T. J., Pasquali J.-L. Structure-function studies on a polyre-active (natural) autoantibody: Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J. Immunol. 1994; 152: 5988–5996
   PubMed Web of Science ®Google Scholar
• Cunliffe D. A., Cox K. O. IgM-autoantibodies against isologous erythrocytes also react with isologous IgG(Fc). Nature 1980; 286: 720–722
   PubMed Web of Science ®Google Scholar
• Keating M. J., Kantarjian H. M., Talpaz M., Redman J., Koller C., Barlogie B., Velasquez W., Plunkett W., Freireich E. J., McCredie K. B. Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25
   PubMed Web of Science ®Google Scholar
• Keating M. J., O'Brien S., Kantarjian H., Plunkett W., Estey E., Koller C., Beran M., Freireich E. J. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878–2884
   PubMed Web of Science ®Google Scholar
• The French Cooperative Group on CLL, Johnson S., Smith A. G., Loffler H., Osby E., Juliusson G., Emmerich B., Wyld P. J., Hiddemann W. Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet 1996; 347: 1432–1438
   PubMed Web of Science ®Google Scholar
• Rai K. R., Peterson B., Elias L., Shepherd L., Hines J., Nelson D., Cheson B., Kolitz J., Schiffer C. A. A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A Calgb, Swog, CTG/NCI-C and Ecog inter-group study. Blood 1996; 88(suppl 1)141a
   Google Scholar
• Myint H., Copplestone J. A., Orchard J., Craig V., Curtis D., Prentice A. G., Hamon M. D., Oscier D. G., Hamblin T. J. Fludarabine-related autoimmune haemolytic anemia in patients with chronic lymphocytic leukemia. Br. J. Haematol. 1995; 91: 341–344
   PubMed Web of Science ®Google Scholar
• Montserrat E., Rozman C. Chronic lymphocytic leukemia: present status. Ann. Oncol. 1995; 6: 219–235
   PubMed Web of Science ®Google Scholar
• Di Raimondo F., Giustolisi R., Cacciola E., O'Brien S., Kantarjian H., Robertson L. B., Keating M. J. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine, Leuk. Lymphoma 1993; 11: 63–68
   PubMed Web of Science ®Google Scholar
• Bastion Y., Coiffier B., Dumontet C., Espinouse D., Bryon P. A. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann. Oncol. 1992; 3: 171–172
   PubMed Web of Science ®Google Scholar
• Byrd J. C., Hertler A. A., Weiss R. B., Freiman J., Kweder S. L., Diehl L. F. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Ann. Oncol 1995; 6: 300–301
   PubMed Web of Science ®Google Scholar
• Lopez L., del Villar V., Pascual T. Fludarabine and fatal hemolytic anemia. Sangre 1995; 40: 335–336
   PubMedGoogle Scholar
• Maclean R., Meiklejohn D., Soutar R. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br. J. Haematol. 1996; 92: 768–769
   PubMed Web of Science ®Google Scholar